Nerve growth factor and pain.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. A variant in MCF2L is associated with osteoarthritis.American journal of human genetics · 2011
   Pooled it
2. The effect on knee-joint load of instruction in analgesic use compared with neuromuscular exercise in patients with knee osteoarthritis: study protocol for a randomized, single-blind, controlled trial (the EXERPHARMA trial).Trials · 2014
   Trial
3. Intravesical nerve growth factor antisense therapy for bladder hypersensitivity induced by psychological stress.Gene therapy · 2024
   Article
4. Confronting the loss of trophic support.Frontiers in molecular neuroscience · 2023
   Article
5. Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments.Osteoarthritis and cartilage open · 2021
   Review
6. [Inflammation and osteoarthritis-related pain].Schmerz (Berlin, Germany) · 2019
   Review
7. Perineural invasion as a prognostic risk factor in patients with early cervical cancer.Oncology letters · 2019
   Article
8. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.Human gene therapy · 2017
   Article
9. Effects of liposome-based local suppression of nerve growth factor in the bladder on autonomic dysreflexia during urinary bladder distention in rats with spinal cord injury.Experimental neurology · 2017
   Article
10. Continuous Low-dose-rate Irradiation of Iodine-125 Seeds Inhibiting Perineural Invasion in Pancreatic Cancer.Chinese medical journal · 2016
    Article
11. Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.PloS one · 2016
    Article
12. Mechanical allodynia.Pflugers Archiv : European journal of physiology · 2015
    Review
13. The future of osteoarthritis therapeutics: emerging biological therapy.Current rheumatology reports · 2013
    Review
14. Advances in osteoarthritis genetics.Journal of medical genetics · 2013
    Review
15. Biologic agents in osteoarthritis: hopes and disappointments.Nature reviews. Rheumatology · 2013
    Review
16. Immunosympathectomy as the first phenotypic knockout with antibodies.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
17. Neurotrophins as regulators of urinary bladder function.Nature reviews. Urology · 2012
    Review
18. Mechanisms of pain in osteoarthritis.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2012
    Article
19. NGF - the TrkA to successful pain treatment.Journal of pain research · 2012
    Article
20. Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody.PloS one · 2012
    Article

Corrections and comments

• Comment on
  Tanezumab for the treatment of pain from osteoarthritis of the knee.2010

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as